baber/WOPTO huggingface dataset:
Patent EP-1333471-A2 (EP)
Inventor: CELII FRANCIS G
IPC: H01L21/3213
Filed: 2003-01-30
Abstract: The present invention is directed to a method of forming an
FeRAM integrated circuit, which includes performing a capacitor
stack etch to define the FeRAM capacitor. The method comprises
etching a PZT ferroelectric layer (126) with a high temperature
BCl 3  etch which provides substantial selectivity with respect to
the hard mask (299). Alternatively, the PZT ferroelectric layer
is etched using a low temperature fluorine component etch
chemistry such as CHF 3  to provide a non-vertical PZT sidewall
profile. Such a profile prevents conductive material associated
with a subsequent bottom electrode layer etch from depositing on
the PZT sidewall, thereby preventing leakage or a "shorting out"
of the resulting FeRAM capacitor.
Patent EP-1445892-A2 (EP)
Inventor: MACNAMEE KEVIN
IPC: H04L29/06
Filed: 2003-12-09
Abstract: A communications traffic acceptance control methods and a Protocol Data Unit
(PDU) filtering gateway are presented. The PDU filtering gateway operates in
accordance with a group of sentry filtering rules and on accepting PDU traffic.
The enhanced PDU filtering gateway selectively generates at run-time
additional dynamic filtering rules. Dynamic PDU acceptance control may be
enforced on communications traffic in the same and/or the opposite
conveyance direction as the first sentry filtering rule triggering PDU. Dynamic
PDU acceptance control may also provide time constraint enforcement on traffic
acceptance. Advantages are derived from a dynamic PDU acceptance control
over connection establishment utilizing reduced resources. New data services
may be accommodated via sentry filtering rule specifications providing
resilience to equipment obsolescence and minimizing code maintenance
overheads.
Patent EP-1467711-A2 (EP)
Inventor: CATCHPOLE IAN RICHARD
IPC: A61K39/39
Filed: 2003-01-23
Abstract: The present invention relates to DNA formulations suitable for ballistic delivery into the skin of the human body. In particular the present invention provides DNA formulations suitable for ballistic administration of DNA vaccines into the skin. The present invention provides a novel DNA pharmaceutical agent dosage form, having a dense core element which is coated with an amorphous solid reservoir medium containing the DNA pharmaceutical agent.
Patent EP-1495444-A2 (EP)
Inventor: HARRIS COLE CORYELL
IPC: G06F19/00
Filed: 2003-03-28
Abstract: L'invention concerne des procédés et dispositifs, notamment des procédés et dispositifs permettant d'estimer une performance d'un classificateur telle qu'une performance de généralisation. Un procédé consiste à produire de multiples échantillons, chaque échantillon étant caractérisé par une ou plusieurs caractéristiques. Ce procédé consiste également à associer une variabilité de caractéristique à au moins une desdites caractéristiques, caractéristique après caractéristique, et à calculer une première probabilité d'erreur de classification par un premier classificateur à l'aide de cette variabilité de caractéristique. Ladite invention concerne également des dispositifs, notamment des circuits intégrés et des réseaux prédiffusés programmables par l'utilisateur (FPGA), configurés pour être utilisés dans la mise en oeuvre desdits procédés.
Patent EP-1517804-A2 (EP)
Inventor: PLESTERNINGS FRANK
IPC: B60J7/20
Filed: 2003-04-08
Abstract: mechanisms each have an upper portion interconnected with the forward end of the decklid and a lower portion interconnected with the vehicle body. The front articulation mechanisms each have a latched position wherein the upper and lower portions are latchedly interconnected and an unlatched position wherein the upper and lower portions are separable. The upper portion includes a multilink hinge having a retracted position and an extended position. A rear articulation mechanism has an upper portion interconnected with the rearward end of the deck and a lower portion interconnected with the vehicle body. The rear articulation mechanism has a latched position wherein the upper and lower portions are latchedly interconnected and an unlatched position wherein the upper and lower portions are separable. The lower portion includes a multilink hinge having a retracted position and an extended position.
Patent EP-1572082-A2 (EP)
Title: Cancer-linked gene as target for chemotherapy
Inventor: YOUNG PAUL E
IPC: G01N33/574
Filed: 2003-03-07
Abstract: Cancer/linked gene sequences, and derved amino acid sequences, are disclosed along with processes for assaying potential antitumor agents based on their modulation of the expression of these cancer-linked genes. Also disclosed are antibodies that react with the disclosed polypeptides and methods of using the antibodies to treat cancerous conditions, such as by using the antibody to target cancerous cells in vivo for purposes of delivering therapeutic agents thereto. Also described are methods of diagnosis using the gene sequences.
Patent EP-1514335-A2 (EP)
Inventor: RESSEL PETER
IPC: H01S5/22
Filed: 2003-05-08
Abstract: The aim of the invention is to simplify known passivation methods. According to said method, the semi-conductor elements are heated and cleaned in a high vacuum with a gaseous, reactive low-energy medium. A closed, insulating or slightly conductive, transparent protective layer is applied in-situ, said layer being inert in relation to the material on the mirror-type surface and the remaining components of a natural oxide. In a preferred embodiment, the optical semi-conductor element is a GaAs-based semi-conductor laser, the reactive and low-energy medium is an atomic hydrogen and the protective layer is made of ZnSe.
Patent EP-1511912-A2 (EP)
Title: Downhole tool deployment safety system and methods
Inventor: JACKSON CAMERON
IPC: E21B47/09
Filed: 2003-05-15
Abstract: A safety system (100) for controlling the activation of one or more downhole tools (112) by providing selective transmission of an activation signal or an energy stream. The transmission of the activation signal or the energy stream is allowed after the tool (112) has passed below a known pre-determined depth. The safety system includes a first device (100A) in fixed relationship with the downhole tool (112) and a second device (100B) fixed a stationary location. The first device (100A) permits, after reaching the pre-determined depth, an initiation signal to reach an initiation device (114) associated with a downhole tool (112) or the energy stream to reach the tool (112). The second device (100B) positively engages the first device (100A) to provide an indication that the specified depth has been reached.
Patent EP-1514180-A2 (EP)
Inventor: FALSETT RAINER
IPC: G06F11/30
Filed: 2003-01-24
Abstract: The invention relates to a method and a device for limiting the response time of a software process to a predefined maximum response time, response time meaning the latency period (period of time between the triggering event and the beginning of the process) added to the time of execution. An example of a software process is an interruption treatment program which is triggered by an interruption signal (interrupt). According to the invention, the software process is split into several partial processes, each of which yields a result. If the software process is interrupted because the maximum response time has elapsed, the result of a previously selected partial process is used as the final result of the process, said partial process being the last one that has been completed, for example.
Patent EP-1553852-A2 (EP)
Inventor: WELLS JR JAMES D
IPC: A41F15/00
Filed: 2003-07-23
Abstract: L'invention concerne un dispositif de protection balistique comprenant un vêtement (12, 14) constitué d'un matériau pare-balles, comprenant un bord périphérique (74, 76) renforcé.
Patent EP-1539821-A2 (EP)
Title: Specific isotype antibodies of secretion-excretion anti-antigens of  i leishmania sp /i  of promastigote i   /i or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effect
Inventor: PAPIEROK GERARD
IPC: C07K16/20
Filed: 2003-07-25
Abstract: The invention concerns immunoglobulins characterized in that they include immunoglobulins of IgG<SUB>2 </SUB>classes and corresponding sub-classes, specific of secretion-excretion antigens of the prosmatigote and asmatigote forms of Leishmania sp, capable of lyzing Leishmania sp amastigotes and promastigotes in vitro, and neutralizing their proliferation.
Patent EP-1549246-A2 (EP)
Inventor: AMBROSE CATHERINE G
IPC: A61K9/26
Filed: 2003-09-05
Abstract: Biodegradable microspheres implanted, injected, or otherwise placed totally or partially within the body are capable of near-linear controlled release of an antibiotic for a predetermined period of time for the treatment and prevention of infections involving the body. The microspheres are formed of polylactic-co-glycolic acid (PLGA) and an effective amount of antibiotic sufficient to produce bactericidal levels in body tissues, and may or may not include polyethylene glycol (PEG). The microspheres exhibit near-linear delivery of the antibiotic for at least 4 weeks at levels exceeding the minimum inhibitory concentration (MIC) for organisms commonly found to be the cause of infections.
Patent EP-1521947-A2 (EP)
Title: Scatter spectra method for x-ray fluorescent analysis with optical components
Inventor: ELAM WILLIAM T
IPC: G01N23/20
Filed: 2003-06-17
Abstract: A method of measuring the transfer function of an X-ray optical component over a wide range of X-ray energies, which includes the steps of:using an X-ray optical component between an X-ray source and a scattering target to obtain a first scatter spectrum; obtaining a second scatter spectrum from the same or a similar target without the X-ray optical component between the X-ray source and the scattering target; andcalculating the ratio of the first scatter spectrum to the second scatter spectrum. The method can be used to improve the accuracy of X-ray quantitative methods in an apparatus where an X-ray optical component is used between the X-ray source and the specimen to be investigated by utilizing the method described above.
Patent EP-1561110-A2 (EP)
Inventor: BELL MICHAEL L
IPC: G01N33/543
Filed: 2003-09-23
Abstract: L'invention concerne des procédures de cytométrie ou analogues dans lesqelles le nombre de différents types de particules identifiables (et, donc, le nombre d'analytes identifiables) est augmenté par l'utilisation de marqueurs de codage sur certaines particules comme marqueurs de signalisation sur d'autres particules; et par l'utilisation de marqueurs de signalisation sur certaines particules comme marqueurs de codage sur d'autres particules. Dans une telle procédure, les particules de la première catégorie sont codées avec des quantités prédéterminées d'une première paire de fluorochromes, et les particules de la seconde catégorie sont codées avec des quantités prédéterminées d'une seconde paire de fluorochromes. Les analytes interagissant avec la première catégorie de particules sont identifiés par un marqueur de signalisation choisi dans la seconde paire, et les analytes interagissant avec la seconde catégorie de particules sont identifiés par un marqueur de signalisation choisi dans la première paire.
Patent EP-1546395-A2 (EP)
Inventor: YANG SHUWEI
IPC: C12N15/90
Filed: 2003-07-28
Abstract: L'invention concerne des vecteurs ADN recombinants et des procédés de clonage et d'expression de molécules d'acide nucléique, au moyen d'une combinaison spécifique du site et de la jonction ou de la liaison bout-à-bout de molécules d'acide nucléique, telle qu'une digestion ou ligation à restriction d'endonucléase. Les vecteurs et procédés ADN peuvent être utilisés pour l'insertion, l'échange et le transfert d'une variété de segment(s) ADN, in vitro  et in vivo. L'invention concerne en outre des molécules et des procédés de liaison, de telles liaisons, pouvant être utilisées pour le clonage d'un gène approprié dans un vecteur d'expression, en une étape. Les séquences de liaison comprennent des séquences d'adaptateur à usage de clonage, ainsi que des sites de liaison au ribosome eucariotes et procariotes pour l'accroissement de l'efficacité de translation.
Patent EP-1554235-A2 (EP)
Inventor: KOCHAT HARRY
IPC: A61K/
Filed: 2003-10-22
Abstract: A process for synthesizing substantially enantiomerically pure L-amino acids, particularly L-gamma-methylene glutamic acid, and esters and salts thereof. The process includes the derivatization of (2S)-pyroglutamic acid, and the decyclization of the resulting derivative to form the desired end product.
Patent EP-1468905-A2 (EP)
Inventor: ACHTZEHN HANS-JUERGEN
IPC: G01M99/00
Filed: 2004-04-02
Abstract: A device for under water testing of equipment parts, especially propellers, involving ultrasonic testing in a nuclear reactor pressure container using a remotely controlled under water vehicle (2) with a carrier (6) on its rear side (4), which can swing only around an axis (10), oriented parallel to the longitudinal axis (8) of the vehicle, which has a holding device (12) for the test head (14), which is located on carrier (6).
Patent EP-1475243-A2 (EP)
Inventor: TAKASU YOUICHI
IPC: B43K7/08
Filed: 2004-05-07
Abstract: A water-based ballpoint pen comprising a specific aqueous
ink, a ball, a ballpoint pen tip for holding said ball at a front
end thereof and for discharging said ink from said top endportion,
an ink follower following said ink with consumption of said ink,
and an ink container directly containing said ink and said ink
follower and for supplying said ink to said tip, said ink container
communicating with a rear portion of said tip, wherein the ink
follower comprises specific at least a base oil and a thickener.
Patent EP-1508876-A2 (EP)
Inventor: TAJIMA JOHJI
IPC: H04N5/74
Filed: 2004-08-20
Abstract: An image projection device includes a distance measuring
device which determines a screen distance between the image
projection device and a screen. An image sensor captures a
shape of the screen and a screen detector detects a sensor-view
shape of the screen from the captured image of the
screen. The sensor-view shape of the screen is transformed to
a projector-view shape of the screen by a coordinate
transformer based on the screen distance. A controller
modifies an image to be projected so as to fit it to the
projector-view shape of the screen. The modified image is
projected on the screen.
Patent EP-1541902-A2 (EP)
Inventor: OCHI TATSUYA
IPC: F16H61/16
Filed: 2004-11-05
Abstract: The invention relates to the control of a gear type transmission. A large gearshift shock
that occurs if a renewed gearshift operation is forcibly carried out in order to meet a new
gearshift request made through a driver's operating an accelerator pedal or a signal from an
operation lever during a current gearshift operation. Gearshift response lag occurs due to an
attempt to avoid the large gearshift shock. To solve these problems, a control system (12) for a
gear type transmission (3) is mounted. The control system (12) is provided with a renewed
gearshift disabling period, during which any renewed gearshift request to a third predetermined
gearshift position made during a gearshift operation from a first predetermined gearshift position
to a second predetermined gearshift position is disabled.
Patent EP-1482723-A2 (EP)
Inventor: OHTSUKA NAOJI
IPC: G09G5/00
Filed: 1997-04-22
Abstract: A user interface for high-quality image output and
an image processing apparatus utilizing the user interface
which performs apparatus setting for appropriate printing
by selecting a print medium and a print mode in accordance
with the type of ink cartridge. When an exchangeable ink
cartridge, containing YMCK color ink or ink having
different ink densities from those of the YMCK color ink
in approximately the same color hues, is attached to a
printer, the type of the ink cartridge is discriminated
by an ink cartridge ID, and available print media and
appropriate output image types are displayed for user's
selection based on the ID. Then print operation is set
in accordance with instruction by the user.
Patent EP-1515336-A2 (EP)
Inventor: WEISS VOLKER DR
IPC: G11B7/24
Filed: 2004-09-10
Abstract: The device (1) has an optically transparent medium disc (2), machine-readable information in a first sub-region (3) of the disc, a second sub-region (4) without machine-readable information and with printed information in at least two layers on one side of the disc. The first layer nearer the carrying layer has visually legible information in mirror text and the second layer has normal text.
Patent EP-1469437-A2 (EP)
Inventor: SCHREYER KARLHEINZ
IPC: G08B25/01
Filed: 2004-02-10
Abstract: Each bidirectional sensor (BT1-BT5) that receives a message sent by a unidirectional sensor (UT1-UT2) waits for an individually-assigned time slot in order to forward it to a central control station (Z). During this time, each sensor checks that another sensor has not already forwarded the message and, if so, suppresses its own forwarding operation. All bi-directional sensors wait for the central station to acknowledge receipt of the message, otherwise, the sensors wait to forward the message. The alarm system operates with a central station (Z) and a number of bi-directional and unidirectional substations (BT, UT) connected by a radio network. The central station and the bidirectional substations can transmit and receive, while the unidirectional substations can only transmit. Unidirectional substations outside the radio receiving range of the central station try to convey messages via one of the bidirectional substations, using the following procedure : (1) the message sent by a unidirectional station is received from all bi-directional participants within radio range; (2) each bidirectional station receiving the message waits for its individually-assigned waiting period to relay the message to the central station; (3) during the waiting period, each bidirectional substation is switched to receive mode, and if a confirmation signal is broadcast from the central station forwarding of the original message from the unidirectional substation is suppressed.
Patent EP-1587762-A2 (EP)
Title: Procede de traitement d'un plan d'eau
Inventor: HAUSIN VOLKER A
IPC: C02F1/32
Filed: 2004-01-05
Abstract: L'invention concerne un procédé de traitement d'un plan d'eau dans lequel un bioréacteur et un éjecteur d'eau sont situés dans un plan d'eau de manière que l'éjecteur soit immergé sous le plan d'eau à une profondeur d'au moins 3 pieds environ. L'éjecteur d'eau produit un flux d'eau à une vitesse d'au moins 60 pieds par minute environ, le flux d'eau étant sensiblement parallèle à la surface du plan d'eau. De l'eau passe également à travers un bioréacteur qui contient une pluralité d'éléments de bio-suspension dans une enveloppe située au-dessus d'un filtre de l'enveloppe.
Patent EP-1593043-A2 (EP)
Inventor: TSIRTSIS GEORGE
IPC: G06F15/173
Filed: 2004-01-26
Abstract: Methods and apparatus for supporting network layer protocol version independent mobility management are described. In accordance with the present invention, the signaling method used to set-up the redirection (encapsulation or tunnel) is separated from the type of redirection being set-up. Through the use of a Protocol Independent Mobility Management Protocol and/or modules for implementing one or more aspects of the Protocol of the present Invention, Mobile IPv4 and IPv6 may run an top of any version of the network layer and can set-up tunnels of any network layer version over any other network layer version. Various features of the invention are used to establish tunnels which are capable of being used to commutate IPv4 and/or IPv6 packets (520, 530). Other features are directed to storing and using state information which allows IPv4 and/or IPv6 packets (520, 530) to be sent through a tunnel established using IPv4 or IPv6 type signaling (512).
Patent EP-1592475-A2 (EP)
Inventor: ZIMMERMAN YOTAM
IPC: A61B18/20
Filed: 2004-02-03
Abstract: L'invention concerne un dispositif destiné à déplacer une source d'énergie thérapeutique au-dessus d'une zone à traiter. Ledit dispositif comprend au moins une source d'énergie thérapeutique conçue pour produire de l'énergie thérapeutique et couplée à une structure de montage, et au moins une unité mobile reliée à la structure de montage et conçue pour déplacer la structure de montage et la source d'énergie couplée à cette structure au-dessus d'une zone à exposer à l'énergie thérapeutique. En outre, cette invention concerne un procédé servant à inhiber essentiellement la croissance capillaire et consistant à appliquer sur une zone de traitement de l'énergie électromagnétique possédant une longueur d'onde qui se situe au sein d'une portée spécifique et une taille de point sensiblement petite, de telle manière qu'au moins une portion du renflement pileux est sensiblement touchée et la papille dermique n'est pratiquement pas touchée.
Patent EP-1595027-A2 (EP)
Inventor: SHANNON THOMAS GERARD
IPC: D21H17/59
Filed: 2004-02-19
Abstract: Cette invention se rapporte à une feuille en papier de soie et/ou à un produit en papier de soie qui comprend une composition de polysiloxane. Cette feuille en papier de soie et/ou ce produit en papier de soie possède une valeur AGAT après vieillissement qui est égale ou supérieure à environ 60 % de la valeur AGAT avant vieillissement, calculée après vieillissement de la feuille en papier de soie et/ou du produit en papier de soie à environ 25 °C pendant environ 28 jours.
Patent EP-1605823-A2 (EP)
Inventor: ZEMAN HERBERT D
IPC: G01N21/35
Filed: 2004-02-25
Abstract: L'invention concerne un système d'imagerie permettant d'éclairer un tissu corporel avec de la lumière infrarouge pour augmenter la visibilité des vaisseaux sanguins sous-cutanés et de produire une image vidéo du tissu corporel et des vaisseaux sanguins sous-cutanés sur la base de la lumière infrarouge réfléchie. Le système comprend une source de lumière infrarouge permettant de produire une lumière infrarouge et une structure permettant de diffuser la lumière infrarouge. Cette structure de diffusion comprend une ou plusieurs couches de matériau de diffusion permettant de diffuser la lumière. Le système comprend également un dispositif d'imagerie vidéo permettant de recevoir la lumière infrarouge réfléchie par le tissu corporel et de produire une image vidéo du tissu corporel sur la base de la lumière infrarouge réfléchie.
Patent EP-1626964-A2 (EP)
Inventor: BESIDSKI YEVGENI
IPC: A61K31/502
Filed: 2004-05-13
Abstract: La présente invention concerne : de nouveaux composés représentés par la formule générale (I), dans laquelle R1 à R9 désignent des éléments définis dans la formule générale (I) ; des sels, des solvates ou des sels solvatés de ces composés ; des procédés destinés à la préparation de ces composés ; de nouveaux intermédiaires utilisés pour la préparation de ces composés ; des préparations pharmaceutiques contenant ces composés ; et l'utilisation de ces composés à des fins thérapeutiques.